Welcome to LookChem.com Sign In|Join Free
  • or
(2-Nitro-4-trifluoroMethyl-phenyl)-carbaMic acid tert-butyl ester, also known as NTCP-carbaMic acid tert-butyl ester, is a tert-butyl ester derivative of a carboxylic acid. It is characterized by a nitro group, a trifluoromethyl group, and a phenyl group attached to a carbaMic acid functional group. This chemical compound has potential uses in medicinal chemistry and drug development due to its unique structure and potential for biological activity. However, it must be handled with care due to its potential toxicity and reactivity. Additional research and testing are needed to fully understand the properties and potential uses of this chemical compound.

579474-18-3

Post Buying Request

579474-18-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

579474-18-3 Usage

Uses

Used in Medicinal Chemistry:
(2-Nitro-4-trifluoroMethyl-phenyl)-carbaMic acid tert-butyl ester is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Drug Development:
(2-Nitro-4-trifluoroMethyl-phenyl)-carbaMic acid tert-butyl ester is used as a precursor in the development of new drugs. Its potential biological activity makes it a promising candidate for further research and testing to determine its efficacy and safety in treating various medical conditions.
Used in Chemical Research:
(2-Nitro-4-trifluoroMethyl-phenyl)-carbaMic acid tert-butyl ester is used as a research compound to study its chemical properties and reactivity. This information can be valuable in understanding its potential applications and limitations in various industries.
Used in Chemical Synthesis:
(2-Nitro-4-trifluoroMethyl-phenyl)-carbaMic acid tert-butyl ester is used as a reactant in various chemical synthesis processes. Its unique functional groups allow for the formation of new compounds with potential applications in different fields.

Check Digit Verification of cas no

The CAS Registry Mumber 579474-18-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,9,4,7 and 4 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 579474-18:
(8*5)+(7*7)+(6*9)+(5*4)+(4*7)+(3*4)+(2*1)+(1*8)=213
213 % 10 = 3
So 579474-18-3 is a valid CAS Registry Number.

579474-18-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Methyl-2-propanyl [2-nitro-4-(trifluoromethyl)phenyl]carbamate

1.2 Other means of identification

Product number -
Other names Methyl (2-nitro-4-trifluoromethylphenyl)acetate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:579474-18-3 SDS

579474-18-3Relevant academic research and scientific papers

NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF

-

Paragraph 0124; 0125; 0127, (2013/03/28)

The present invention relates to novel benzodiazepinone compounds of Formulae (I) wherein R1, R2, R4, R6, R7, R8, R9, and R10 are as defined herein. The invention also

2-Benzimidazolyl-9-(chroman-4-yl)-purinone derivatives as JAK3 inhibitors

Cole, Andrew G.,Bohnstedt, Adolph C.,Paradkar, Vidyadhar,Kingsbury, Celia,Quintero, Jorge G.,Park, Haengsoon,Lu, Yingchun,You, Ming,Neagu, Irina,Diller, David J.,Letourneau, Jeffrey J.,Shao, Yuefei,James, Ray A.,Riviello, Christopher M.,Ho, Koc-Kan,Lin, Tsung H.,Wang, Bojing,Appell, Kenneth C.,Sills, Matthew,Quadros, Elizabeth,Kimble, Earl F.,Ohlmeyer, Michael H.J.,Webb, Maria L.

scheme or table, p. 6788 - 6792 (2010/06/12)

A novel class of Janus tyrosine kinase 3 (JAK3) inhibitors based on a 2-benzimidazoylpurinone core structure is described. Through substitution of the benzimidazoyl moiety and optimization of the N-9 substituent of the purinone, compound 24 was identified incorporating a chroman-based functional group. Compound 24 shows excellent kinase activity, good oral bioavailability and demonstrates efficacy in an acute mechanistic mouse model through inhibition of interleukin-2 (IL-2) induced interferon-γ (INF-γ) production.

Dihydro-benzo[b][1,4]diazepin-2-one derivatives

-

, (2008/06/13)

This invention relates to dihydro-benzo[b][1,4]diazepin-2-one derivatives of the formula wherein R1, R2, X and Y are as defined in the specification and R3 is a six-membered aromatic heterocycle containing 1 to 3 nitrogen atoms or a pyridine-N-oxide as further defined in the specification. The invention further relates to medicaments containing these compounds, a process for their preparation as well as their use for preparation of medicaments for the treatment or prevention of acute and/or chronic neurological disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 579474-18-3